The effect of hypopituitarism on fatigue after subarachnoid hemorrhage

L. Khajeh; G. M. Ribbers; M. H. Heijenbrok-Kal; K. Blijdorp; D. W.J. Dippel; E. M. Sneekes; H. J.G. van den Berg-Emons; A. J. van der Lely; S. J.C.M.M. Neggers; F. van Kooten

doi:10.1111/ene.13014

The effect of hypopituitarism on fatigue after subarachnoid hemorrhage

L. Khajeh, G. M. Ribbers, M. H. Heijenbrok-Kal, K. Blijdorp, D. W.J. Dippel, E. M. Sneekes, H. J.G. van den Berg-Emons, A. J. van der Lely, S. J.C.M.M. Neggers, F. van Kooten

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Abstract

Background and purpose: Aneurysmal subarachnoid hemorrhage (SAH) survivors often complain of fatigue, which is disabling. Fatigue is also a common symptom of pituitary dysfunction (PD), in particular in patients with growth hormone deficiency (GHD). A possible association between fatigue after SAH and long-term pituitary deficiency in SAH survivors has not yet been established. Methods: A single center observational study was conducted amongst 84 aneurysmal SAH survivors to study the relationship between PD and fatigue over time after SAH, using mixed model analysis. Fatigue was measured with the Fatigue Severity Scale and its relationships with other clinical variables were studied. Results: Three-quarters of respondents (76%) have pathological fatigue directly after SAH and almost two-thirds (60%) of patients still have pathological levels of fatigue after 14 months. The severity of SAH measured with a World Federation of Neurosurgical Societies (WFNS) score higher than 1 (P = 0.008) was associated with long-term fatigue. There is no statistically significant effect of PD (P = 0.8) or GHD (P = 0.23) on fatigue in SAH survivors over time. Conclusions: Fatigue is a common symptom amongst SAH survivors. WFNS is a usable clinical determinant of fatigue in SAH survivors. Neither PD nor GHD has a significant effect on long-term fatigue after SAH.

Original language	English
Pages (from-to)	1269-1274
Number of pages	6
Journal	European Journal of Neurology
Volume	23
Issue number	8
DOIs	https://doi.org/10.1111/ene.13014
Publication status	Published - 1 Aug 2016
Externally published	Yes

Keywords

fatigue
growth hormone deficiency
hypopituitarism
subarachnoid hemorrhage

Access to Document

10.1111/ene.13014

Cite this

@article{889e2899b1c74add8b15e89fef70da8f,

title = "The effect of hypopituitarism on fatigue after subarachnoid hemorrhage",

abstract = "Background and purpose: Aneurysmal subarachnoid hemorrhage (SAH) survivors often complain of fatigue, which is disabling. Fatigue is also a common symptom of pituitary dysfunction (PD), in particular in patients with growth hormone deficiency (GHD). A possible association between fatigue after SAH and long-term pituitary deficiency in SAH survivors has not yet been established. Methods: A single center observational study was conducted amongst 84 aneurysmal SAH survivors to study the relationship between PD and fatigue over time after SAH, using mixed model analysis. Fatigue was measured with the Fatigue Severity Scale and its relationships with other clinical variables were studied. Results: Three-quarters of respondents (76%) have pathological fatigue directly after SAH and almost two-thirds (60%) of patients still have pathological levels of fatigue after 14 months. The severity of SAH measured with a World Federation of Neurosurgical Societies (WFNS) score higher than 1 (P = 0.008) was associated with long-term fatigue. There is no statistically significant effect of PD (P = 0.8) or GHD (P = 0.23) on fatigue in SAH survivors over time. Conclusions: Fatigue is a common symptom amongst SAH survivors. WFNS is a usable clinical determinant of fatigue in SAH survivors. Neither PD nor GHD has a significant effect on long-term fatigue after SAH.",

keywords = "fatigue, growth hormone deficiency, hypopituitarism, subarachnoid hemorrhage",

author = "L. Khajeh and Ribbers, {G. M.} and Heijenbrok-Kal, {M. H.} and K. Blijdorp and Dippel, {D. W.J.} and Sneekes, {E. M.} and {van den Berg-Emons}, {H. J.G.} and {van der Lely}, {A. J.} and Neggers, {S. J.C.M.M.} and {van Kooten}, F.",

note = "Publisher Copyright: {\textcopyright} 2016 EAN",

year = "2016",

month = aug,

day = "1",

doi = "10.1111/ene.13014",

language = "English",

volume = "23",

pages = "1269--1274",

journal = "European Journal of Neurology",

issn = "1351-5101",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

TY - JOUR

T1 - The effect of hypopituitarism on fatigue after subarachnoid hemorrhage

AU - Khajeh, L.

AU - Ribbers, G. M.

AU - Heijenbrok-Kal, M. H.

AU - Blijdorp, K.

AU - Dippel, D. W.J.

AU - Sneekes, E. M.

AU - van den Berg-Emons, H. J.G.

AU - van der Lely, A. J.

AU - Neggers, S. J.C.M.M.

AU - van Kooten, F.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Background and purpose: Aneurysmal subarachnoid hemorrhage (SAH) survivors often complain of fatigue, which is disabling. Fatigue is also a common symptom of pituitary dysfunction (PD), in particular in patients with growth hormone deficiency (GHD). A possible association between fatigue after SAH and long-term pituitary deficiency in SAH survivors has not yet been established. Methods: A single center observational study was conducted amongst 84 aneurysmal SAH survivors to study the relationship between PD and fatigue over time after SAH, using mixed model analysis. Fatigue was measured with the Fatigue Severity Scale and its relationships with other clinical variables were studied. Results: Three-quarters of respondents (76%) have pathological fatigue directly after SAH and almost two-thirds (60%) of patients still have pathological levels of fatigue after 14 months. The severity of SAH measured with a World Federation of Neurosurgical Societies (WFNS) score higher than 1 (P = 0.008) was associated with long-term fatigue. There is no statistically significant effect of PD (P = 0.8) or GHD (P = 0.23) on fatigue in SAH survivors over time. Conclusions: Fatigue is a common symptom amongst SAH survivors. WFNS is a usable clinical determinant of fatigue in SAH survivors. Neither PD nor GHD has a significant effect on long-term fatigue after SAH.

AB - Background and purpose: Aneurysmal subarachnoid hemorrhage (SAH) survivors often complain of fatigue, which is disabling. Fatigue is also a common symptom of pituitary dysfunction (PD), in particular in patients with growth hormone deficiency (GHD). A possible association between fatigue after SAH and long-term pituitary deficiency in SAH survivors has not yet been established. Methods: A single center observational study was conducted amongst 84 aneurysmal SAH survivors to study the relationship between PD and fatigue over time after SAH, using mixed model analysis. Fatigue was measured with the Fatigue Severity Scale and its relationships with other clinical variables were studied. Results: Three-quarters of respondents (76%) have pathological fatigue directly after SAH and almost two-thirds (60%) of patients still have pathological levels of fatigue after 14 months. The severity of SAH measured with a World Federation of Neurosurgical Societies (WFNS) score higher than 1 (P = 0.008) was associated with long-term fatigue. There is no statistically significant effect of PD (P = 0.8) or GHD (P = 0.23) on fatigue in SAH survivors over time. Conclusions: Fatigue is a common symptom amongst SAH survivors. WFNS is a usable clinical determinant of fatigue in SAH survivors. Neither PD nor GHD has a significant effect on long-term fatigue after SAH.

KW - fatigue

KW - growth hormone deficiency

KW - hypopituitarism

KW - subarachnoid hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=84978524248&partnerID=8YFLogxK

U2 - 10.1111/ene.13014

DO - 10.1111/ene.13014

M3 - Article

C2 - 27128968

AN - SCOPUS:84978524248

SN - 1351-5101

VL - 23

SP - 1269

EP - 1274

JO - European Journal of Neurology

JF - European Journal of Neurology

IS - 8

ER -

The effect of hypopituitarism on fatigue after subarachnoid hemorrhage

Abstract

Keywords

Access to Document

Fingerprint

Cite this